Please assess the completion status of the following clinical trial:

Trial Title: Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Rest pain, gangrene or ulcers located below the patella for a duration of at least two weeks (either one of these criteria are sufficient).~* One measurement of: Ankle blood pressure(ABP) \<70 mm Hg, an toe blood pressure(TBP) \<50, or a TcPO2\<45 mm Hg, or an ankle/brachial pressure index \<0.7 (either one of these criteria are sufficient).~* Informed consent obtained~Exclusion Criteria:~* Age \< 55 years~* Women of childbearing potential~* Patients already medicating with Pregabalin or Gabapentin~* Creatinine clearance \<30ml/min~* Amputation necessary within two weeks~* Revascularization necessary within two weeks (open vascular surgery or endovascular)~* A medical history of clear dizziness~* NYHA class IV heart failure~* Known hypotension, or having a systolic arm blood pressure \<120 mm Hg (two consecutive measurements with the patient lying supine)~* Simultaneous or previous (within 30 days prior to study entry participation in a clinical study using experimental drugs or devices~* Mental condition making the subject unable to understand the concepts and risk of the study~* Known allergies against pregabalin

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): Active intervention with pregabalin
- B (Type: PLACEBO_COMPARATOR): placebo arm with capsule Lyrica Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).